Keep it in your carry-on luggage, never in checked bags where cargo hold temperatures can fluctuate dramatically
Use It Correctly: More frequent dosing is not better
Online platform agrees to stop selling GLP-1 drugs to US customers An international online platform settled with the Connecticut attorney general's office Wednesday and agreed to stop selling GLP-1 weight-loss medications to customers in the United States, according to a press release from the attorney general's office
Rani Aravamudhan, senior medical director at Nomi Health, agrees, noting that "it's no surprise that a wave of GLP-1 or Ozempic alternatives has hit the market, many claiming similar effects." She adds that the trend has fueled a growing supplement industry, often backed by celebrity endorsements and social media influencers
Without the mega marketing budgets of multinational brands, Replenza gained traction thanks to influencers who posted about how it improved their daily lives